Law Practice
Dec. 24, 2008
Off-Label Drug Suits Are Off Limits, Court Says
Drugmakers that push medicines for dangerous off-label uses to boost profits are off-limits to plaintiffs and civil suits, a federal judge has ruled in dismissing a major nationwide case against Amgen.
Daily Journal Staff Writer LOS ANGELES - Drugmakers that push medicines for dangerous off-label uses to boost profits are off-limits to plaintiffs and civil suits, a federal judge has ruled in dismissing a major nationwide case against Amgen. Policing illegal drug marketing is the job of federal regulators - not private parties - according to last week's decision, which could thwart dozens of lawsuits across the industry. I...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In